enVVeno Medical Corp Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
enVVeno Medical Corp (NVNO) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.20% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-26
- enVVeno Medical Corp effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 0.20%.
- enVVeno Medical Corp effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.50%.
- enVVeno Medical Corp effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.50%.
- enVVeno Medical Corp effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.10%, a 120.00% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2025-12-31 | 0.20% 10-K · filed 2026-03-26 |
| 2024-12-31 | -0.50% 10-K · filed 2025-02-28 |
| 2023-12-31 | -0.50% 10-K · filed 2025-02-28 |
| 2022-12-31 | -0.10% 10-K · filed 2024-02-29 |
| 2021-12-31 | 0.50% 10-K · filed 2023-03-02 |
| 2020-12-31 | -0.70% 10-K · filed 2022-03-28 |
| 2019-12-31 | 2.10% 10-K · filed 2021-03-31 |
| 2018-12-31 | -0.90% 10-K · filed 2020-03-18 |
| 2017-12-31 | 1.30% 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |